Eli Lilly's experimental drug, lepodisiran, shows promise in reducing lipoprotein(a) levels, a genetic risk factor for cardiovascular disease, in a Phase 2 trial.
Top Netanyahu aides arrested in 'Qatargate' scandal, as investigation into alleged unlawful connections deepens.
Eli Lilly's experimental drug, lepodisiran, shows promise in reducing lipoprotein(a) levels, a genetic risk factor for cardiovascular disease, in a Phase 2 trial.
Top Netanyahu aides arrested in 'Qatargate' scandal, as investigation into alleged unlawful connections deepens.